Pharmaceuticals

Drug Formulation Market to Grow at a CAGR of 9.1% from 2025 to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Drug Formulation Market?

The drug formulation market size has seen robust expansion in recent years. It is forecast to grow from $1908.89 billion in 2024 to $2045.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. This historical growth can be attributed to biopharmaceutical innovations, patient-centric approaches in drug development, personalized medicine, regulatory support for orphan drugs, and increased investment in research and development.

The drug formulation market is projected to experience substantial expansion in the coming years. By 2029, its size is anticipated to reach $2894.29 billion, expanding at a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period is attributable to progress in 3D printing, an emphasis on pediatric formulations, biological drug delivery systems, the adoption of green chemistry in formulation, and the integration of artificial intelligence (AI). Key trends expected during this period encompass the prevalence of biopharmaceuticals and biologics, advanced drug delivery systems, personalized medicine and tailored formulations, the integration of nanotechnology, and lifecycle management and reformulation approaches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

Which Drivers Are Supporting Growth Of The Drug Formulation Market?

The escalating incidence of chronic diseases is projected to boost the growth of the drug formulation market. Chronic diseases are conditions defined by a duration of one year or more, requiring continuous medical attention, limiting daily activities, or both. Drug formulation can help reduce the prevalence of such illnesses by employing various drug delivery methods to optimize therapeutic effectiveness and minimize adverse effects through its influence on medication absorption, distribution, metabolism, and excretion. For instance, a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in September 2022, indicated that in 2023, the United States is predicted to see a 99.5% increase in people aged 50 and older with at least one chronic illness, rising from 71.52 million in 2020 to 142.66 million in 2050. Furthermore, the number of individuals with multimorbidity is projected to climb by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the increasing prevalence of chronic diseases is significantly driving the expansion of the drug formulation market.

How Is The Drug Formulation Market Classified Into Different Segments?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

How Are Emerging Market Trends Shaping The Drug Formulation Industry Landscape?

A significant trend that is increasingly prevalent within the drug formulation market involves technological advancements. Leading entities active in the drug formulation sector are focusing their endeavors on rolling out novel and sophisticated technologies, aiming to bolster their standing in the industry. As an illustration, in June 2022, Merck & Co., Inc., a US-based pharmaceutical company, inaugurated the Merck Digital Sciences Studio (MDSS), established to facilitate the development of groundbreaking technologies for drug research and development. Merck leverages the robust computing capabilities of Azure Clouds along with its discovery and clinical specialists to collaboratively expedite and adopt cutting-edge digital technologies. The MDSS represents a collaborative initiative between Merck and the New Jersey Innovation Institute (NJII), a US-based entity under the ownership of the New Jersey Institute of Technology. Investments in this project have been made by The Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures. Microsoft is committed to offering technology support to emerging start-up companies involved.

Which Industry Leaders Are Driving Innovation Across The Drug Formulation Market?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Which Regional Markets Are Contributing Most To The Drug Formulation Industry Expansion?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Drug Formulation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

Browse Through More Reports Similar to the Global Drug Formulation Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795